tiprankstipranks
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
PremiumPress ReleasesNuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
2M ago
Nuvalent initiated with a Buy at Jefferies
PremiumThe Fly
Nuvalent initiated with a Buy at Jefferies
3M ago
Nuvalent presents data on NVL-330, zidesamtinib at AACR
PremiumThe Fly
Nuvalent presents data on NVL-330, zidesamtinib at AACR
3M ago
Nuvalent assumed with a Buy at Guggenheim
PremiumThe FlyNuvalent assumed with a Buy at Guggenheim
5M ago
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
5M ago
Nuvalent granted  breakthrough therapy designation to NVL-520 by FDA
PremiumThe Fly
Nuvalent granted breakthrough therapy designation to NVL-520 by FDA
5M ago
Nuvalent price target raised to $80 from $70 at Piper Sandler
PremiumThe FlyNuvalent price target raised to $80 from $70 at Piper Sandler
6M ago
Nuvalent announces “OnTarget 2026” operating plan
PremiumThe Fly
Nuvalent announces “OnTarget 2026” operating plan
7M ago
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results
PremiumPress Releases
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100